SCORR Marketing

Trending Articles

  1. LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
  2. Fasenra for EGPA: addressing unmet needs Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
  3. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  4. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
  5. Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Recruitment

Jane Byram joins SCORR Marketing
Regulatory

New Industry Forum to Advance Clinical Trial Participation

4–5 April 2018 | Conference | Maryland, USA
Marketing

Four promoted at SCORR marketing

SCORR Marketing announces the promotions of Lauren Naughton, Ashlee Swanson, Marc Bacon and Holli Kroeker

Health Care Business Development Executive Joins SCORR Marketing

Kelly DeBoer joins SCORR Marketing as director of health care.
Media

Health Care Business Development Executive Joins SCORR Marketing

SCORR Marketing, a global health science marketing and communications firm, has announced the appointment of Kelly DeBoer as director of health care.
Subscribe now